Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity reactions to amsacrine.

D J Perry, R B Weiss, D F Hoth

    Cancer Treatment Reports
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Hypersensitivity reactions to amsacrine, a chemotherapy drug, are rare but serious. This review found an approximate incidence of 0.4% in patients treated for various cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2020
    Same author

    Factor X and its deficiency states.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Laboratory monitoring of haemostasis.

    Anaesthesia·2014
    Same author

    Genetic testing in bleeding disorders.

    Haemophilia : the official journal of the World Federation of Hemophilia·2014
    Same author

    Recurrent pregnancy loss and thrombophilia.

    The Ceylon medical journal·2014
    Same author

    Pollen pool heterogeneity in jack pine (Pinus banksiana Lamb.): a problem for estimating outcrossing rates?

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
    Same journal

    Rhabdomyolysis associated with high-dose cytarabine.

    Cancer treatment reports·1987
    Same journal

    Acute laryngeal edema after single-dose irradiation and doxorubicin.

    Cancer treatment reports·1987
    Same journal

    Timing may be a critical factor in drug therapy.

    Cancer treatment reports·1987
    Same journal

    Prednimustine in advanced malignant melanoma: a phase II study.

    Cancer treatment reports·1987
    Same journal

    Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    Same journal

    Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    See all related articles

    Area of Science:

    • Oncology
    • Clinical Pharmacology
    • Immunology

    Background:

    • Amsacrine is an antineoplastic agent used in treating various malignancies.
    • Hypersensitivity reactions (HSRs) are potential adverse events associated with drug therapies.
    • Understanding the incidence of HSRs is crucial for patient safety and treatment protocols.

    Observation:

    • Five new cases of amsacrine-induced hypersensitivity reactions were identified.
    • These cases were analyzed in conjunction with three previously reported instances.
    • A comprehensive review of 62 reports detailing amsacrine's clinical use was conducted.

    Findings:

    • The review encompassed 2095 patients treated with amsacrine for solid tumors and hematological malignancies.
    • A total of nine cases of hypersensitivity were documented across these clinical trials.

    Related Experiment Videos

  • The approximate incidence of hypersensitivity reactions to amsacrine was calculated to be 0.4%.

    • Implications:

    • The findings suggest a low but present risk of hypersensitivity to amsacrine.
    • This data is vital for oncologists when assessing patient risk and managing amsacrine therapy.
    • Further pharmacovigilance may be warranted to fully characterize amsacrine-related hypersensitivity events.